Table 1 Clinical Baseline Characteristics
All patients, n = 45 | No. (%) |  |  |  |
|---|---|---|---|---|
Sex | Male | Female | Â | Â |
31 (68.9) | 14 (31.1) | Â | Â | |
Age (years) | ≤ 60 | > 60 | Median |  |
26 (57.8) | 19 (42.2) | 59 | Â | |
ECOG performance status | ≤ 1 | ≥ 2 |  |  |
32(71.1) | 13 (28.9) | Â | Â | |
BMI | Median (range) | Â | Â | Â |
24.3 (17.3–31.8) |  |  |  | |
Smoking history | Never | Current or former | unknown | Â |
9 (20.0) | 32 (71.1) | 4 (8.9) | Â | |
Treatment stage | First-line | Second-line | Third-line and more | Â |
12 (26.7) | 28 (62.2) | 5 (11.1) | Â | |
Immunotherapy mode | ICI | ICI + CT | ICI + VEGFR | ICI + CT + VEGFR |
10 (22.2) | 24 (53.3) | 8 (17.8) | 3 (6.7) | |
Irradiated site | Brain | Bone | Lung (drainage area lymph node) | Â |
22 (48.9) | 13 (28.9) | 10 (22.2) | Â | |
RT modality | CFRT | SBRT | Â | Â |
44 (97.8) | 1 (2.2) | Â | Â |